BioMers

About BioMers

BioMers operates in the medical device sector with a focus on aesthetic orthodontic solutions. The company was established in 2005 as a spin-off from the National University of Singapore, where its core technology was developed. The CEO is Dr. Mervyn Fathianathan. BioMers has secured a total of $4.82 million in funding over three rounds from five investors, with the latest seed round occurring on November 8, 2011.

The company's primary business involves the design, manufacturing, and sale of advanced orthodontic systems to clinicians. Its business model appears to be a direct-sales approach to orthodontic professionals, who then offer the system to their patients. For a flat fee, clinicians receive a comprehensive package that includes customized archwires, brackets in indirect transfer trays, and retainers, eliminating hidden costs for mid-course corrections. To use the system, orthodontists must undergo training and are then listed in the SimpliClear provider network, a directory for prospective patients.

BioMers' flagship product is SimpliClear, marketed as the world's first completely clear braces system. Unlike traditional braces that use metal, or other aesthetic options that only feature clear brackets, SimpliClear utilizes a translucent polymer composite archwire, making the entire appliance virtually invisible. This is achieved through a patented nanotechnology that provides the polymer wires with mechanical properties comparable to metal, allowing them to treat a full range of malocclusions, from mild to severe cases. The system is customized for each patient; clinicians submit impressions and a prescription, and BioMers fabricates the custom appliance. A key benefit is that the system is metal-free, making it an ideal choice for patients with nickel or other metal allergies. The company launched SimpliClear Express for minor misalignments and later introduced SimpliClear Full for comprehensive treatments.